Scalable, User-Friendly Data Management Solution Offers Innovation, Integration, and Transparency for Pharma Operations. SOFIA, BG / ACCESS Newswire / January 20, 2025 / A leading global ...

The rise in Venus Remedies share price came after the company announced the renewal of its European GMP certification by ...

The certification covers the company’s manufacturing facility for cephalosporin, carbapenem, and lyophilized injectable ...

Telangana: Gland Pharma has received Establishment Inspection Report (EIR) from the United States Food and Drug ...

The Indian government wants micro, small, and medium drugmakers to meet WHO GMP standards by the end of 2025 or face shutdown ...

The company is going to announce its earnings for the quarter and nine months ended December 31, 2024 on February 3, 2025.

What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...

Gland Pharma receives EIR from US FDA for Dundigal facility, indicating closure of inspection with no major concerns.

Stallion India IPO, which is worth ₹199.45 crore, comprises a fresh issue of ₹160.73 crore, and an offer-for-sale (OFS) of 43 ...

The company had earlier announced that the US FDA awarded it a Good Manufacturing Practice (GMP) certification on July 25, 2024, concerning an inspection conducted at Gland Pharma’s Dundigal facility.